经颈动脉血运重建联合动态血流逆转治疗对侧颈动脉闭塞患者的结局
基于血管质量倡议数据库2016年9月至2019年5月的5485例经颈动脉血运重建(TCAR)病例,其中593例(10.8%)存在对侧颈动脉闭塞(CCO)。分析显示CCO患者院内卒中或死亡与无CCO者无显著差异,但症状性既往卒中患者中CCO与卒中或死亡风险显著升高相关。
要点
- TCAR在CCO患者中总体安全,院内卒中/死亡与无CCO者无显著差异。
- 症状性既往卒中患者中,CCO与卒中或死亡风险显著升高相关(OR 4.63)。
- 无症状CCO患者 outcomes 与无CCO者无显著差异。
核心结论
- TCAR在CCO患者中似乎安全,但症状性既往卒中患者需谨慎。
研究设计与样本
- 回顾性队列研究,纳入血管质量倡议数据库中2016年9月至2019年5月接受TCAR联合血流逆转的患者5485例。
主要发现
- CCO患者平均血流逆转时间较短(10.1±6.7分钟 vs 11.1±7.8分钟;P<.01)。
- CCO患者术中神经功能改变发生率为1%,无CCO者为0.7%(P=.43)。
- 单变量分析显示CCO与无CCO患者院内卒中或死亡无显著差异(1.7% vs 1.5%;P=.65)。
- 调整基线差异后,CCO患者院内卒中/死亡的调整OR为1.39(95%CI 0.65-3.0;P=.40),无统计学意义。
- 症状性既往卒中患者中,CCO与卒中或死亡风险显著升高相关(OR 4.63;95%CI 1.39-15.4;P=.01)。
临床怎么用
- TCAR可用于CCO患者,但症状性既往卒中患者需评估风险。
局限性
- 需要更大样本和更长随访研究评估TCAR在CCO患者中的围手术期和长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The outcomes of carotid revascularization in patients with contralateral carotid artery occlusion (CCO) are controversial. CCO has been defined by the Centers for Medicare and Medicaid Services as a high-risk criterion and is used as an indication for transfemoral carotid artery stenting. With the promising outcomes associated with transcarotid artery revascularization (TCAR), we aimed to study the perioperative outcomes of TCAR in patients with CCO and to assess the feasibility of TCAR in these high-risk patients. METHODS: All patients in the Vascular Quality Initiative database who underwent TCAR with flow reversal between September 2016 and May 2019 were included. Patients with trauma, dissection, or more than two treated lesions were excluded. Univariable and multivariable logistic analyses were used to compare the primary outcome of in-hospital stroke or death after TCAR in patients with CCO and those without CCO (patent and <99% stenosis). Secondary outcomes included intraoperative neurologic changes and the individual outcomes of in-hospital stroke, death, and myocardial infarction as well as 30-day mortality. RESULTS: A total of 5485 TCAR cases were included, of which 593 (10.8%) had CCO. In patients with CCO, mean flow reversal time was shorter (10.1 ± 6.7 minutes vs 11.1 ± 7.8 minutes; P < .01); intraoperative neurologic changes occurred in 1% of these patients compared with 0.7% of those with patent contralateral carotid arteries (P = .43). On univariable analysis, no significant difference in in-hospital stroke or death was shown between patients with and patients without CCO (1.7% vs 1.5%; P = .65). Similarly, no significant differences were noted between the groups in terms of in-hospital death (0.7% vs 0.4%; P = .27), stroke (1.7% vs 1.2%; P = .32), and stroke/death/myocardial infarction (2.2% vs 1.8%; P = .53) as well as 30-day mortality (0.8% vs 0.6%; P = .55). The results remained statistically nonsignificant after adjustment for baseline differences between the groups; the adjusted odds ratio (OR) of in-hospital stroke/death in patients with CCO compared with those with patent contralateral carotid arteries was not significant (OR, 1.39; 95% confidence interval, 0.65-3.0; P = .40). In symptomatic patients presenting with prior stroke, CCO was associated with significantly higher odds of stroke or death (OR, 4.63; 95% confidence interval, 1.39-15.4; P = .01) compared with no CCO. On the other hand, in asymptomatic patients, no significant difference in outcomes was observed between the groups. CONCLUSIONS: In this analysis, TCAR seems to be safe in patients with CCO. Caution should be taken in symptomatic patients with CCO and a history of prior stroke as they might have worse outcomes compared with patients with patent contralateral carotid arteries. Studies with larger sample size and longer follow-up are needed to assess the perioperative and long-term outcomes of TCAR in patients with CCO in comparison to other procedures.
引用
- Dakour-Aridi H, Schermerhorn ML, Husain F, et al. Outcomes of transcarotid artery revascularization with dynamic flow reversal in patients with contralateral carotid artery occlusion. J Vasc Surg. 2020. PMID: 32569716. doi:10.1016/j.jvs.2020.04.529
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。